Alabama
Birmingham; Children's Hospital of Alabama
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Birmingham; University of Alabama at Birmingham
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Arizona
Phoenix; Phoenix Children's Hospital
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Phoenix; Hope Research Institute, LLC
Are you interested in alternative investigational methods to possibly keep your ULCERATIVE COLITIS in remission?
Phoenix; Redpoint Research
Ulcerative Colitis
Tucson; Arizona Clinical Research Center, Inc.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Arkansas
Fayetteville; First Care Family Doctors South
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Little Rock; Little Rock Diagnostic Clinic
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
California
Anaheim; AGMG Clinical Research
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Anaheim; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Buena Park; Unified Research
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Encinitas; Discovery Clinical Research
Do You Have Ulcerative Colitis (Encinitas)
Garden Grove; Digestive Liver Disease Specialists, Medical Group
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Long Beach; Long Beach VA Medical Center
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Los Angeles; Cedars Sinai Medical Center
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Los Angeles; Cedars-Sinai Medical Center, Department of Psychiatry and Mental Health
Single Dose, Placebo Controlled Study of MDX-1100 in Patients With Active Ulcerative Colitis
Los Angeles; Cedars Sinai School of Medicine - IBD Center
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
Orange; Community Clinical Trials
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Orange; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Orange; Community Clinical Trials
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Roseville; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Roseville; Capital Gastroenterology Consultants of Sacramento
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
San Diego; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Colorado
Aurora; The Children's Hospital
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Engelwod; South Denver Gastroenterology
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Golden; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Golden; Rocky Mountain Clinical Research
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Littleton; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Littleton; Arapahoe Gastroenterology
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Wheat Ridge; Western States Clinical Research, Inc.
New Research Study for Moderately to Severely Active Ulcerative Colitis
Wheat Ridge; Western States Clinical Research, Inc.
Ulcerative Colitis Research Study
Connecticut
Bristol; Connecticut Gastroenterology Institute
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Bristol; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Bristol; CT Gastroenterology Institute
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Hartford; Connecticut Children's Medical Center
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Stratford; Clinical Research Consultants
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Florida
Jacksonville; Research Center![[*]](../images/newtiny.gif)
Moderate to Severe Ulcerative Colitis Clinical Research Study
Boca Raton; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Brooksville; Clinical Research of Tampa Bay, Inc.
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
DeLand; University Clinical Research DeLand, LLC
Ulcerative Colitis
Gainesville; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Gainesville; University of Florida
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Hialeah; Medical Research Unlimited
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Hollywood; Southern Clinical Research Consultants
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Hollywood; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Hollywood; Gastroenterology Consultants, P.A.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Inverness; Florida Wellcare Alliance
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Jacksonville; Borland Groover Clinic
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Jacksonville; Borland-Groover Clinic
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Jacksonville; Borland Groover Clinic
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Largo; DMI Research
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
New Port Richey; Advanced Research Institute
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
North Miami Beach; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
North Miami Beach; Venture Research Institute
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Orlando; Nemour's Children's Clinic
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Ormond Beach; Peninsula Research, Inc.
Ulcerative Colitis
Ormond Beach; Peninsula Research Inc.
Do you have Ulcerative Colitis?
Palm Harbor; Advanced Gastroenterology Associates
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Tampa; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Tampa; Florida Medical Clinic
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
West Palm Beach; Metabolic Research Institute, Inc.
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Winter Park; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Winter Park; Shafran Gastroenterology Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Georgia
Atlanta; Neeman Medical International
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Atlanta; Children's Center for Digestive Health Care
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Atlanta; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Atlanta; Atlanta Gastroenterology Associates
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Atlanta; Consultative Gastroenterology
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Atlanta; Digestive Healthcare of Georgia
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Austell; GI Diagnostics
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Decatur; The Atlanta Center for Gastroenterology
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Macon; Gastroenterology Associates of Central Georgia
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Savannah; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Savannah; St. Joseph's/Candler Health System
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Illinois
Arlington Heights; Northwest Gastroenterologists S.C.
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Chicago; Illinois Center for Clinical Research
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Chicago; The University of Chicago Hospitals
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Chicago; University of Chicago Hospitals
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Chicago; Rush University Medical Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Glenview; Evanston Northwestern Healthcare
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Indiana
Indianapolis; Riley Hospital for Children
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Iowa
Clive; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Clive; Iowa Digestive Disease Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Fort Dodge; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Fort Dodge; Trimark Physicians Group
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Waterloo; Medical Arts Center
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Kansas
Pratt; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Topeka; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Topeka; Cotton O'Neil Digestive Health Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Topeka; Cotton-O'Neil Digestive Health Center
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Kentucky
Lexington; University of Kentucky Medical Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Lexington; University of Kentucky Chandler Medical Center
Do you have Crohns disease or ulcerative colitis?
Lexington; University of Kentucky Chandler Medical Center
Do you have Crohns disease or ulcerative colitis?
Lexington; University of Kentucky Chandler Medical Center
Relatives of Inflammatory Bowel Disease Patients Needed for Health Questionnaire
Louisville; The Childrens Foundation Building
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Louisville; University of Louisville
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Louisiana
Monroe; Bhandari, Baj Raj
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Slidell; Medical Research Institute, Inc.
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Maryland
Chevy Chase; Chevy Chase Clinical Research Metropolitan Gastroenterology Group
Single Dose, Placebo Controlled Study of MDX-1100 in Patients With Active Ulcerative Colitis
Chevy Chase; Chevy Chase Clinical Research/Metropolitan Gastroenterology Group
Do you suffer from Ulcerative Colitis?
Chevy Chase; Metropolitan Gastroenetrology Group Chevy Chase Clinical Research
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
Hagerstown; Washington County Hospital
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Hagerstown; The Center for Clinical Research at Washington County Hospital
A Multicenter, Randomized, Double-Blind, Actively Controlled Trial to Evaluate the Safety and Efficacy of a New Tablet Formulation and Dosing Regimen of Balsalazide Disodium 3.3G BID vs. Mesalamine (5-ASA) as Asacol 0.8G TID
in Mildly to Moderately Active Ulcerative Colitis
Laurel; Maryland Digestive Disease Research
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Laurel; Maryland Digestive Disease Research, LLC
Do you or a family member suffer from Ulcerative Colitis?
Silver Spring; Capital Gastroenterology Consultants, P.A.
Study for patients with active Ulcerative Colitis
Massachusetts
Boston; Mass General Hospital for Children
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Michigan
Chesterfield; Clinical Research Institute of Michigan, LLC
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Dearborn; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Dearborn; The Center for Clinical Studies
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Troy; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Troy; Center for Digestive Health
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Minnesota
Minneapolis; University of Minnesota
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Rochester; Mayo Clinic Rochester
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Mississippi
Tupelo; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Tupelo; Digestive Health Specialists
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Missouri
Kansas City; Bradley Freilich, MD, LLC
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Mexico; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Mexico; Center for Digestive and Liver Diseases, Inc.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
St. Louis; St. Louis Center for Clinical Research
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
St. Louis; Washington University School of Medicine
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
New Hampshire
Lebanon; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Lebanon; Dartmouth-Hitchcock Medical Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
New Jersey
Cedar Knolls; Gastroenterology Research Associates, LLC
Just hanging in there with your Ulcerative Colitis?
Egg Harbor; AGA Clinical Research Associates, LLC
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Egg Harbor Township; Atlantic Gastroenterology Associates
How do UC Life?
Egg Harbor Twp.; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Egg Harbor Twp.; Atlantic Gastroenterology Associates
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Florham Park; Affiliates in Gastroenterology
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
New Brunswick; UMDNJ - RWJMS
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
New Brunswick; UMDNJ-RWJMS
Single Dose, Placebo Controlled Study of MDX-1100 in Patients With Active Ulcerative Colitis
New Brunswick; University of Medicine and Dentistry of New Jersey
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
Ocean; Shore Health Group
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
New York
Great Neck; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Huntington; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
New Hyde Park; North Shore- LIJ Health System
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
New Hyde Park; Biomedical Research Alliance of New York
Children and Adolescents with Mildly-to-Moderately Active Ulcerative Colitis
New Hyde Park; Biomedical Research Alliance of New York
Children ages 6-17 with moderate to severe ulcerative colitis (UC)
New York; Simon Lichtiger, MD
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
New York; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
New York; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
New York; Simon Lichtiger, MD
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
New York; New York Presbyterian Hospital
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
New York; Research Associates of New York
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
New York; Mount Sinai Medical Center
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid Refractory Ulcerative Colitis [291-415]
New York; Mount Sinai School of Medicine
Single Dose, Placebo Controlled Study of MDX-1100 in Patients With Active Ulcerative Colitis
New York; Mount Sinai Medical Center
A Phase I, Blinded, Multicenter, Dose-escalation, Placebo-controlled, Single-dose Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Patients with Active Ulcerative Colitis [MDX1100-01]
New York; Mount Sinai Medical Center
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Visilizumab in Subjects with Intravenous Steroid Refractory Ulcerative Colitis [291-415]
New York; Research Associates of New York
Clinical Study for Patients with Active Ulcerative Colitis (UC)
New York; Mount Sinai Medical Center
A Phase I, Multicenter, Dose-escalation, Study of MDX-1100 (anti-CXCL10 Human Monoclonal Antibody) in Patients with Active Ulcerative Colitis [MDX1100-01]
New York; Mount Sinai School of Medicine
The study is designed to determine how safe and effective MDX 1100 (fully human antibody) is when given to patients with active ulcerative colitis.
Northport; VA Medical Center, Northport
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Rochester; Rochester Institute for Digestive Diseases & Sciences, Inc
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Syracuse; Veterans Affairs Medical Center
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Syracuse; Institute for Human Performance
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Troy; Upstate Gastroenterology Associates, PC
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
North Carolina
Asheville; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Asheville; Asheville Gastroenterology Associates, P.A.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Boone; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Boone; Medispect, LLC
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Cary; Cary Medical Group
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Cary; Triangle Medical Research Associates
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Charlotte; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Charlotte; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Charlotte; Carolina Digestive Health Associates
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Charlotte; Charlotte Gastroentology and Hepatology, P.L.L.C
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Durham; Duke University Medical Center
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Greensboro; LeBauer Research Associates, PA
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Greenville; Carolina Research
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
High Point; Bethany Medical Center
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Kinston; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Morganton; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
New Bern; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
New Bern; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
New Bern; Southern Gastroenterology Associates
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Raleigh; Wake Research Associates, LLC
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Raleigh; Wake Research Associates
Just hanging in there with your Ulcerative Colitis?
Raleigh; Multi-Specialty Research Associates of NC
Do you have ulcerative colitis in remission?
Raleigh; Wake Research Associates
Ulcerative Colitis?
Rutherford College; Burke Research Associates
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Wilmington; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Wilmington; Hanover Medical Specialists, P.A.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Winston Salem; Wake Forest University Baptist Medical Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
North Dakota
Fargo; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Fargo; Odyssey Research
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Fargo; Odyssey Research Services
An Ulcerative Colitis Research Study
Ohio
Cincinnati; Consultants for Clinical Research, Inc.
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Cincinnati; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Cincinnati; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Cincinnati; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Cincinnati; Gastroenterology Research Consultants of Greater Cincinnati
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Cincinnati; Consultants for Clinical Research Inc.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Cleveland; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Cleveland; Case Medical Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Cleveland; Cleveland Clinic Foundation
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Columbus; Columbus Children's Hospital, PCTI
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Columbus; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Columbus; Remington-Davis, Inc.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Dayton; Wright State University School of Medicine
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Warren; Avamar Center for Endoscopy
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Oklahoma
Norman; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Norman; Central Sooner Research
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Oklahoma City; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Oklahoma City; Oklahoma Foundation for Digestive Research
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Tulsa; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Tulsa; Gastroenterology United of Tulsa
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Oregon
Portland; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Portland; West Hills Gastroenterology Research
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Portland; Oregon Health & Science University
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Portland; Portland Clinic
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Pennsylvania
Philadelphia; The Children's Hospital of Philadelphia
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Rhode Island
Providence; Rhode Island Hospital
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
South Carolina
Charleston; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Charleston; Medical University of South Carolina (MUSC)
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Columbia; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Columbia; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Columbia; Consultants in Gastroenterology
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Columbia; Columbia Gastroenterology Associates
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Simpsonville; Hillcrest Clinical Research LLC
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Tennessee
Germantown; Gastroenterology Center of the MidSouth, PC
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Nashville; Nashville Medical Research Institute
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Nashville; Vanderbilt University Medical Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Texas
Austin; Austin Gastroenterology, PA
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Galveston; University of Texas Medical Branch
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Houston; NationsMed Clinical Research
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Houston; Atilla Ertan, MD, PA
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Houston; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Houston; Ertan, Atilla (private practice)
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Utah
Ogden; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
South Ogden; Advanced Research Institute
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Vermont
Burlington; Fletcher Allen Health Care
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Virginia
Chesapeake; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Chesapeake; Gastroenterology Associates of Tidewater
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Christiansburg; New River Research Institute
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Christiansburg; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Christiansburg; New River Valley Research Institute
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Richmond; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Richmond; McGuire VA Medical Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Roanoke; Summit Medical Research Ltd
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Washington
Bellevue; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Bellevue; Northwest Gastroenterology Associates
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Spokane; Spokane Digestive Disease Center
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Spokane; Eastern Washington Clinical Research Center
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Spokane; Spokane Digestive Disease Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Tacoma; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Tacoma; Digestive Health Specialists
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Wisconsin
Madison; University of Wisconsin Madison Medical School
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Madison; Dean Foundation for Health, Research and Education, Inc.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Milwaukee; Wisconsin Center for Advanced Research
No More UC A research study for adults with mild to moderate ulcerative colitis currently in remission.
Milwaukee; Medical College of Wisconsin
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Milwaukee; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Milwaukee; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Milwaukee; Advanced Healthcare, SC-Clinical Research Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Milwaukee; Wisconsin Center for Advanced Research
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Milwaukee; Medical College of Wisconsin
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
International
Calgary, Alberta, Canada; University of Calgary
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Edmonton, AB, Canada; Aberthart Centre #1
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Halifax, NS, Canada; IWK Health Centre
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Hamilton, ON, Canada; McMaster Children's Hospital
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Hamilton, ON, CANADA; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Hamilton, Ontario, Canada; McMaster University Health Sciences Center
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Kingston, Ontario, Canada; Hotel Dieu Hospital - Kingston
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
London, ON, CANADA; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
London, Ontario, Canada; London Health Science Centre
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Montreal, Quebec, Canada; CHUM Hopital Saint-Luc
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Montreal, Quebec, Canada; Montreal General Hospital
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Montreal, Quebec, Canada; Hôpital Maisonneuve - Rosemont
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Montreal, Quebec, Canada; Jewish General Hospital
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Ottawa, Ontario, Canada; Hassard, Philip MD
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Quebec, Canada; CHAUQ - Hopital du St-Sacrement
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Saskatoon, SK, Canada; Medical Digestive
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Saskatoon, SK, Canada; Edwin Larkai Medical Professional Corporation
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Toronto, ON, Canada; The Hospital for Sick Children
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Toronto, ON, CANADA; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Toronto, Ontario, Canada; Toronto Digestive Disease Associates, Inc.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Vancouver, BC, Canada; B.C. Children's Hospital
Does your child have Ulcerative Colitis? You may want to look into our research study available for children with moderately to severely active Ulcerative Colitis (UC).
Vancouver, British Columbia, Canada; Liver and Intestinal Research Centre
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Victoria, British Columbia, Canada; PerCuro Clinical Research Ltd.
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Intravenously, in Subjects With Moderately to Severely Active Ulcerative Colitis
Winnipeg, MB, CANADA; Research Center
Moderate to Severe Ulcerative Colitis Clinical Research Study
Winnipeg, MB, Canada; Health Sciences Centre
A Phase 2/3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety and Efficacy of Golimumab Induction Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis
